/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
Pfizer Inc. (PFE), founded in 1849 and headquartered in New York City, is one of the world's largest pharmaceutical companies dedicated to developing and delivering innovative medicines and vaccines. With a market cap of $151.6 billion, Pfizer serves millions of patients globally, addressing a wide range of therapeutic areas and advancing healthcare through cutting-edge research and development.
Shares of Pfizer have significantly underperformed the broader market over the past 52 weeks. PFE stock has dropped 3.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 22.6%. In 2025, shares of PFE gained marginally, compared to SPX's 2.7% gain on a YTD basis.